CD40L-transfected myeloma cells transfer prolonged immunity in vivo.
Ingo G.H. Schmidt‐Wolf(University Hospital Bonn), Peter Brossart(University of Bonn), John Strehl(University of Bonn), Elisabeth Sievers(Karolinska University Hospital), Marcus Gorschlüter(University of Bonn)
PubMed
April 14, 2010
Cited by 1
Related Papers
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450
Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation
|Blood|2014|400
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394